INTRODUCTION
Dysregulation of mRNA metabolism has emerged as a significant factor in human disease pathologies, with proper control of mRNA transcription, processing, nuclear export, translation, and turnover being critical to cellular homeostasis, signaling, division, and differentiation (Cooper et al., 2009; Hurt and Silver, 2008; Renoux and Todd, 2012) . Gle1 is an essential multifunctional protein, conserved from yeasts to humans, that plays a direct role in both mRNA export and translation (Bolger et al., 2008; Murphy and Wente, 1996; Watkins et al., 1998) . Mutations in the human (h) GLE1 gene are responsible for the autosomal recessive lethal congenital contracture syndrome-1 (LCCS1) disease (Nousiainen et al., 2008) . LCCS1 is a severe in utero form of a heterogeneous group of disorders, termed arthrogryposis multiplex congenita, that occur in 1 of 3,000 human births worldwide (Hall, 1985) . LCCS1 disease pathology is characterized by lack of anterior horn motor neurons and severe atrophy of ventral spinal cord, along with joint and jaw deformities (Herva et al., 1985) . Recent work indicates the pathological basis of this disease is attributed to a reduction in Gle1 activity causing the apoptosis of proliferative organ precursors during early development (Jao et al., 2012) . However, in LCCS1, the primary molecular defects in hGle1 cellular roles are unknown.
Previous studies have revealed multiple aspects of Gle1 structure and function in the budding yeast (y) Saccharomyces cerevisiae and human cells (Figures 1A and 1B) . The C-terminal domains have extensive conservation, with 27% identical and 27% similar residues found between the regions by reported sequence alignments (from residues 250-538 for yGle1 and 360-659 for hGle1; Watkins et al., 1998) . Further, both have significant spans in their N-terminal regions that are predicted to form coiled-coil structures (Watkins et al., 1998) . For mRNA export, hGle1 docks at the nuclear pore complex (NPC) through interactions with the NPC proteins hNup155 and hCG1 (yNup42 for yGle1; Kendirgi et al., 2005; Murphy and Wente, 1996; Rayala et al., 2004; Strahm et al., 1999; Stutz et al., 1997) . hGle1 is also dynamic, and its shuttling between the nucleoplasm and cytoplasm is essential for efficient mRNA export in human cells (Kendirgi et al., 2003) . Although humans have a single copy of the hGLE1 gene, there are at least two alternatively spliced isoforms (hGle1A and hGle1B; Kendirgi et al., 2003) . Whereas hGle1B has distinct steady-state localization at the NPC, the hGle1A isoform lacks the C-terminal hCG1-binding domain and is predominantly cytoplasmic. Thus, there are potentially distinct subcellular pools of hGle1A and hGle1B that might reflect multiple roles in gene expression.
During mRNA export and translation, yGle1 regulates the RNA-dependent ATPase activities of specific DEAD-box proteins (DBPs), thus controlling the action of these DBPs in nucleotide-dependent unwinding of RNA duplexes and/or remodeling of the mRNA-particle (mRNP) protein composition (Alcá zarRomá n et Bolger et al., 2008; Bolger and Wente, 2011; Weirich et al., 2006) . Efficient yGle1 function at the NPC requires inositol hexakisphosphate (IP 6 ,) binding (Alcá zar-Romá n et al., 2010; York et al., 1999) , and together, yGle1-IP 6 triggers Dbp5-dependent mRNP remodeling events required for directional export through NPCs (Tran et al., 2007) . Conserved residues in both yGle1 and hGle1 are critical for IP 6 binding and Dbp5 activation (Figures 1A and 1B; Alcá zar-Romá n et al., 2010; Montpetit et al., 2011) . In translation termination, yGle1-IP 6 directly interacts with Sup45 (eRF1) and is thought to activate Dbp5 for RNP remodeling to promote Sup35 (eRF3) association (Bolger et al., 2008) . During translation initiation, yGle1 and hGle1 interact with eIF3 proteins, and yGle1 is known to modulate a different DBP, Ded1, for efficient start site recognition (Bolger et al., 2008; Bolger and Wente, 2011) . Thus, Gle1 serves as a multifunctional effector of distinct steps in the gene expression pathway.
The major LCCS1 causative mutation in hGLE1 is designated Fin Major and is a single nucleotide substitution that alters a splice site acceptor in the third intron (Nousiainen et al., 2008) . This results in a three amino acid residue insertion (proline-phenylalanine-glutamine [PFQ] ) in the N-terminal coiled-coil domain of hGle1. LCCS1 patients are typically homozygous for the Fin Major mutation, whereas heterozygotes show no reported phenotype (Nousiainen et al., 2008) . As noted above, the C-terminal domain of hGle1 is linked to DBP regulation, nucleocytoplasmic shut- (A) Diagram depicting functional and structural domains in S. cerevisiae (y)Gle1. Black arrow represents the position of the y-gle1-4 mutation (G382R; Watkins et al., 1998) . White arrow marks the location of conserved IP 6 -coordinating residues K377 and K378 (Alcá zar-Romá n et al., 2010). (B) Diagram depicting functional and structural domains in human (h)Gle1B (adapted from Kendirgi et al., 2005) . ''PFQ'' denotes location of the Fin Major insertion after amino acid 144 in the predicted coiled-coil domain (Nousiainen et al., 2008) . Black arrow represents the homologous position (Q548) of the residue mutated in y-gle1-4 (Watkins et al., 1998) . White arrow marks the location of conserved IP 6 -coordinating residues K526 and K527 (Alcá zar-Romá n et al., 2010). (C) Paircoil2-generated structure predictions of Gle1 polypeptide sequences, showing the structural effect of h-gle1-Fin Major and y-gle1-engineered PFQ insertions. (+) indicates >50% probability of coiled-coil structure. PFQ insertions locations are designated by bold underlined typeface. See Tables S1 and S2 for Paircoil2  scores and p values. tling, and IP 6 binding (Alcá zar-Romá n et al., 2010; Kendirgi et al., 2003; Montpetit et al., 2011; Weirich et al., 2006) . The N-terminal coiled-coil domain is also essential in vivo (Watkins et al., 1998) ; however, putative protein interaction partners for the coiled-coil domain have not been defined. It is also unclear whether the coiled-coil domain is involved in mRNA export and/or translation or how it is functionally perturbed in human LCCS1 disease.
Here, we investigated the function of the coiled-coil domain and, in doing so, defined the underlying mechanism for LCCS1 at the molecular level. We show that the coiled-coil domain is critical for Gle1 self-association. Moreover, both hGle1 oligomerization and mRNA export functions are perturbed with the Fin Major protein. For yGle1, the coiled-coil domain is specifically required for mRNA export and not translation. These data reveal a step in the mRNA export pathway and provide direct evidence for a defect in hGle1 regulation of mRNA export at the NPC as the molecular mechanism causing the human LCCS1 disease.
RESULTS

Gle1 Self-Associates In Vitro via Its Coiled-Coil Domain
To date, no protein interaction partners for the Gle1 coiled-coil domain have been reported. Because coiled-coil domains are often utilized to mediate homotypic interactions, we speculated that Gle1 might self-associate. To test this, a series of in vitro biochemical experiments were conducted with recombinant purified proteins. First, for in vitro soluble binding assays, a glutathione S-transferase (GST)-tagged N-terminal region of hGle1 (residues 1-362; GST-hGle1(1-362)) was expressed and purified from bacteria. Figure S1A available online). This suggested that the coiled-coil domain is sufficient to mediate self-association.
As an independent assessment of Gle1 self-association, sedimentation velocity analytical ultracentrifugation (SVAU) was employed. For this, recombinant maltose-binding protein (MBP)-hGle1(1-362) was purified from bacteria ( Figure S1B ). MBP-hGle1(1-362) protomer itself has a predicted molecular mass of 0.084 MDa. Strikingly, MBP-hGle1(1-362) sedimented in a series of distinct peaks corresponding to at least eight species with high relative molecular masses ranging from 0.096 MDa to 2.0 MDa ( Figure S2A ). As controls, we examined purified MBP alone and a purified recombinant yGle1 polypeptide for the C-terminal domain (residues 241-538; yGle1(241-538)) by SVAU. For both, a single peak of low molecular mass was observed at 0.044 and 0.040 MDa, respectively (Figures S2C and S2D) . Overall, the N-terminal coiled-coil domain of hGle1 was both necessary and sufficient to form large in vitro complexes potentially representing higher-order oligomers. Next, the oligomeric state of recombinant MBP-h-gle1(1-365)-Fin Major was analyzed by SVAU. Similar to wild-type, MBP-h-gle1(1-365)-Fin Major sedimented in a series of distinct peaks ranging from 0.097 MDa to 1.9 MDa ( Figure S2B ). Thus, the Fin Major protein also self-associated and formed oligomeric complexes.
hGle1 Oligomers Form Disk Structures that Are Disorganized with Fin Major To gain insight into the hGle1 oligomer structure, the high-molecular-mass MBP-hGle1(1-362) complexes were analyzed using negative stain electron microscopy (EM). Purified, recombinant MBP-hGle1(1-362) samples at $0.5 mg/ml were further fractionated by size exclusion chromatography. Negative stain EM revealed that MBP-hGle1(1-362) formed ring/disk structures, as shown in a representative field (Figure 2A ) and the montage of individual ring/disks ( Figure 2B ). Measurements of the diameter for 500 particles ranged from $15 nm to 60 nm, with an average size of 25.8 nm (SD of 6.64 nm; Figure 2F ). To further investigate the structures, cryo-electron microscopy (cryo-EM) was conducted, allowing preservation of native protein structure and eliminating negative staining artifacts. The cryo-EM images showed that MBP-hGle1(1-362) oligomers adopted a disk-like shape in solution ( Figure 2G ).
We next examined recombinant MBP-h-gle1(1-365)-Fin Major protein by negative stain EM. MBP-h-gle1(1-365)-Fin Major also formed disk-shaped particles; however, these appeared structurally disorganized compared to wild-type disks ( Figures 2C  and 2D ). Fields of particles from independent purifications were compared and individual particles binned into three distinct structural categories: (1) aggregates; (2) disordered disks; and (3) round disks ( Figure 2E) . A significantly greater proportion of the MBP-h-gle1(1-365)-Fin Major particle samples were disordered disks. We concluded that the PFQ insertion perturbs the in vitro oligomeric complex.
Gle1 Oligomerization Is Structurally Conserved
We hypothesized that recombinant yGle1 would also form disklike oligomeric structures. To investigate this, recombinant, untagged, full-length yGle1 was purified and further fractionated by size exclusion chromatography. By negative stain EM, similar to MBP-hGle1(1-362), yGle1 formed disk-like structures ( Figures  2H and 2I) . Importantly, as isolation of untagged full-length hGle1 was technically not possible, analysis of full-length, untagged yGle1 provided strong evidence that disk structure formation was intrinsic to Gle1 and not an artifact of either the MBP tag or an isolated N-terminal domain. Moreover, the structural characteristics of the oligomer were conserved between yGle1 and hGle1.
hGle1 Self-Associates in Living Cells
To test whether hGle1 self-associates in human cells, Forster resonance energy transfer (FRET) microscopy was used. Plasmids expressing hGle1B tagged with mVenus (Venus) or mCerulean3 (Cer3) were cotransfected into HeLa cells. FRET measurements were made in living cells 12 hr posttransfection using photoacceptor bleaching FRET microscopy ( Figure 3A ). Strikingly, a FRET interaction of Cer3-hGle1B and Venus-hGle1B was detected in the cytoplasm (9.19% FRET efficiency) and in the nucleoplasm (5.85% FRET efficiency). In comparison, the percent FRET efficiency between Cer3 alone and Venus-hGle1B was low (<1.25%) in both the cytoplasm and nucleoplasm. As an additional control, a Venus fusion protein for only the hGle1B C-terminal region (residues 362-698) was tested. Only low FRET efficiency (<2.0%) for both the nucleoplasm and cytoplasm was detected with coexpression of Cer3-hGle1B and VenushGle1B(362-698) ( Figure 3A) . Thus, the coiled-coil domain was required to mediate hGle1B self-association in living cells.
During the acceptor-bleaching event ($50 s), subtle movement of the nuclear rim prevented accurate FRET measurements using the photoacceptor bleaching method. Thus, sensitized emission FRET measurements were made. In cells expressing Cer3-hGle1B and Venus-hGle1B, we observed a normalized FRET (NFRET) signal in the cytoplasm (12.9), nucleoplasm (6.22), and at the nuclear rim (12.8; Figure 3B ). In cells expressing Cer3 and Venus-hGle1B cells, low NFRET (<4.08) signal was detected in all respective locations ( Figure 3B ). Together, these results indicated that hGle1 has the capacity to self-associate, at a minimum, as a dimer pair in living cells.
Fin Major Perturbs Essential hGle1 Function in mRNA Export
To investigate whether the Fin Major phenotype is due to perturbed mRNA export, translation initiation, and/or translation termination, several independent tests were conducted. Our previous studies found that hGle1 localization at the NPC is dependent on interactions with both hNup155 and hCG1 (Kendirgi et al., 2005; Rayala et al., 2004) and that hGle1 interacts with the translation initiation factor eIF3f (Bolger et al., 2008) . Using the yeast two-hybrid assay, G BD -hGle1B and G BD -Fin Major DNA-binding domain (BD) bait proteins were analyzed with respective activation domain (AD) G AD -hCG1, G AD -hNup155, or G AD -eIF3f prey proteins, with b-galactosidase expression as the interaction readout. In all cases, the G BD -Fin Major was similar to wild-type G BD -hGle1B ( Figure S3A ). This suggested that the Fin Major protein was properly folded. Furthermore, the hCG1, Nup155, and eIF3f interactions were not perturbed by the PFQ insertion ( Figure S3A ).
Because the LCCS1 disease is a homozygous recessive condition, we established a siRNA knockdown and add-back human cell culture model system. As confirmed by immunoblotting, endogenous hGle1 levels were reduced by transfection of a small interfering RNA (siRNA) targeting hGLE1 ( Figure 4A , lane 2). As a control, a scrambled siRNA was tested in parallel (CTRL). To assay mRNA export, the cellular distribution of bulk poly(A) + RNA in hGLE1 and CTRL siRNA cells was monitored by in situ hybridization with an oligo (dT) probe. Only cells treated with the hGLE1 siRNA showed robust nuclear accumulation of poly(A) + RNA ( Figure 4B ). Rescue of the mRNA export defect was analyzed by expressing either GFP alone, a GFP-tagged siRNA-resistant (R) hGLE1B gene (GFP-hGLE1B R ), or a GFP-tagged siRNA-resistant Fin Major gene (GFP-Fin Major R ). For each trial, the nuclear/cytoplasmic (N/C) ratio of the poly(A) + RNA distribution was determined by measuring fluorescence intensity. For CTRL siRNA with expression of GFP, GFP-hGLE1B R , or GFP-Fin Major R , the mean N/C ratio was $1.2, with no significant difference between the three conditions. In contrast, the mean N/C ratio for expression of only GFP with the hGLE1 siRNA was $1.6, reflecting nuclear accumulation. Importantly, expression of GFP-hGLE1B R with the hGLE1 siRNA rescued the mRNA export defect (mean N/C ratio = 1.2) confirming that the hGLE1 siRNA phenotype was not due to off-target effects ( Figures 4B and S3B ). However, most strikingly, expression of the GFP-Fin Major R did not rescue ( Figure 4A , lane 6) proteins. Moreover, similar to GFP-hGle1B R , the GFP-Fin Major R localized to the nuclear rim in both the CTRL and hGLE1 siRNA cells ( Figure 6B ). Thus, we concluded that Fin Major is defective for function in mRNA export. we conducted a series of experiments with yGle1. First, to directly test whether the yGle1 N-terminal region impacts Dbp5 activation, purified recombinant MPB-yGle1 proteins were assayed for in vitro Dbp5 ATPase stimulation. As reported, the C-terminal region of yGle1 (residues 241-538; D240Gle1) with IP 6 is sufficient for stimulating Dbp5's ATPase activity ( Figure S4A ; Weirich et al., 2006) . In side-by-side assays, the relative stimulation activity levels for full-length yGle1 and y-D240Gle1 were similar ( Figure S4A ). Thus, in vitro activation Dbp5 did not require a functional yGle1 N-terminal coiled-coil domain.
Based on the sequence and structural homologies and the fact that the hGle1 coiled-coil domain can partially complement the role of the yGle1 domain (Watkins et al., 1998) , we designed Fin Major mimic insertions in yGle1 for tests of in vivo function. In silico analysis with the Paircoil2 coiled-coil prediction program showed that insertion of a three amino acid PFQ motif after amino acid 136 or 149 in yGle1 would potentially disrupt coiled-coil formation in a manner that would effectively mimic the structural effects of the PFQ found after residue 144 in the Fin Major protein ( Figure 1C ; Tables S1 and S2; Nousiainen et al., 2008) . Importantly, the modeling analysis also predicted regions of the yGle1 coiled-coil domain that should be impacted less by a PFQ insertion. For example, adding PFQ after amino acid 157 in yGle1 was not predicted to change the potential for the region to form a coiled-coil ( Figure 1C ; Table S2 ). Based on this, y-gle1-136^P FQ , y-gle1-149^P
FQ
, and y-gle1-157^P FQ mutants were generated. The mutant strains showed no growth defects compared to wild-type yGLE1, indicating no global folding defects for the proteins ( Figure 5A ). Moreover, purified recombinant MBP-y-gle1-136^P FQ and MBP-y-gle1-149^P FQ proteins activated Dbp5 to the same relative level as wild-type MBP-yGle1 ( Figure S4A ). In addition, live-cell, direct fluorescence microscopy of yeast cells showed that the GFP-tagged y-gle1^P FQ proteins localized predominantly at the nuclear rim in a similar manner to wild-type GFP-yGle1 ( Figure S5G ) and GFP-Fin Major in HeLa cells ( Figure 6B ). Next, synthetic fitness defects were tested for double mutants generated from the pairwise combination of the respective y-gle1^P FQ mutants with mRNA export and/or translation mutants. This included several mRNA-export-specific mutants (nup100D, nup42D, and rat7-1(nup159)), a translation initiation mutant (nip1-1), a translation termination mutant (sup45-2), and two mutants with defects in both mRNA export and translation termination (rat8-2(dbp5) and ipk1D; Bolger et al., 2008; Murphy and Wente, 1996; Stutz et al., 1997) . The y-gle1-157^P FQ mutant did not have synthetic fitness defects in any of the tested double mutants ( Figures 5B, S4B , and S4C), correlating with the prediction that it would not perturb the coiled-coil region. Strikingly, the y-gle1-136^P
FQ and y-gle1-149^P FQ mutants had no effect when combined with either nip1-1 or sup45-2. However, the y-gle1-136^P FQ and y-gle1-149^P FQ mutants were synthetically lethal when combined with the nup100D or the rat7-1(nup159) mutant ( Figure 5B ). The y-gle1-136^P FQ was also synthetically lethal with nup42D ( Figure 5B ). This revealed a separation of function with the y-gle1-136^P FQ and y-gle1-149^P FQ mutants having defects in mRNA export and not in translation.
In combination with the ipk1D or the rat8-2(dbp5) mutant, only the y-gle1-136^P FQ allele showed synthetic growth defects compared to the single mutants ( Figures S4B and S4C ). Given that ipk1D double mutants were viable at the permissive growth temperature and that Ipk1 (for IP 6 production) is required for both mRNA export and translation termination (Bolger et al., 2008) , the y-gle1^P FQ ipk1D mutants were excellent candidates for assaying functional effects. After shifting to the nonpermissive growth temperature of 37 C, a significant percentage of the y-gle1-136^P FQ ipk1D and the y-gle1-149^P FQ ipk1D cells showed nuclear poly(A) + RNA accumulation, whereas the y-gle1-157^P FQ ipk1D cells did not exhibit a defect ( Figures 5C   and S4D ). Next, a plasmid-based reporter assay was used to assess translation termination. By monitoring for production of tandem b-galactosidase/luciferase proteins that are separated by either a stop codon, a stem loop, or no stop codon in their intervening linker, the level of stop codon readthrough was determined (Stahl et al., 1995) . As reported (Bolger et al., 2008 ; Alcá zar-Romá n et al., 2010), the ipk1D single mutant had $25% readthrough. In comparison, no enhanced defects in termination efficiency were detected for any of the ipk1D y-gle1^P FQ double mutants ( Figure 5D ). As an independent test for translation initiation, we investigated whether expression of a y-gle1DCC mutant (with an internal in-frame deletion of the sequence encoding the coiled-coil domain) suppressed the growth defects linked to translation initiation in the y-gle1-2 nip1-1 mutant ( Figure 5E ). This was indeed observed. In contrast, y-gle1DCC expression did not rescue the mRNA export defect in y-gle1-4 cells ( Figure 5C ). Thus, y-gle1^P FQ mutants that mimic Fin Major had specific defects in mRNA export that correlated with the Fin Major results.
yGle1 Oligomerization Is Required In Vivo
We previously showed that expression of a chimeric yeasthuman Gle1 protein rescues temperature-sensitive growth properties of a y-gle1-4 S. cerevisiae mutant (Watkins et al., 1998) . Specifically, when the sequence encoding the essential coiledcoil domain of yGle1 is deleted (y-gle1DCC), it can be replaced by an in-frame fragment encoding the coiled-coil domain of hGle1 (+hGLE1 CC; Figure 5F ). We further tested a Fin Major coiled-coil (+Fin Major CC) chimera, and it rescued growth of the y-gle1-4 strain at 30 C to a similar level as the hGle1-CC chimera. However, neither the hGle1-CC nor the Fin Major -CC chimera complemented a lethal y-gle1D mutant. This indicated that the y-gle1DCC+hGLE1-CC was not fully functional, and in the context of the chimera, the hGle1-CC domain was potentially perturbed in a manner similar to Fin Major . Building on this, we investigated whether swapping in a heterologous oligomerization domain would complement functionality in vivo. Expression of a chimeric protein with the coiled-coil region of yGle1 swapped for that of the well-characterized transcription factor Gcn4 (O'Shea et al., 1991; +GCN4) partially rescued the temperature-sensitive y-gle1-4 phenotype ( Figure 5F ), revealing that oligomerization is important for yGle1 function in vivo.
Nucleocytoplasmic Shuttling of Fin Major Is Inhibited
Proper hGle1 nucleocytoplasmic shuttling is critical for mRNA export and requires a unique 39-amino-acid span in the C-terminal region ( Figure 1B ; Kendirgi et al., 2003) . Given that Fin Major was defective in mRNA export and oligomer structure but still showed steady-state localization at the nuclear rim ( Figure 6B ), we examined GFP-Fin Major dynamics in living cells using fluorescence recovery after photobleaching (FRAP). Due to the homozygous recessive Fin Major disease phenotype, experiments were conducted in HeLa cells with and without hGLE1 siRNA treatment (as in Figure 3) . Nuclei of cells transiently expressing a respective GFP-tagged protein were photobleached, and the nuclear GFP fluorescence was monitored over time (Figures 6 and S5) . The FRAP data sets were fit with a one-phase exponential association model. Importantly, the relative half-time (t 1/2 ) for wild-type GFP-hGle1B nuclear signal after FRAP in untreated HeLa cells ( Figures 6A and 6C ) was 12.3 min and correlated with our previous measurements by fluorescence loss in photobleaching (Kendirgi et al., 2003) . When GFPFin Major was assayed by FRAP in untreated cells, the t 1/2 was not significantly different from wild-type GFP-hGle1B ( Figures  6A and 6C ). This was expected due to the homozygous recessive nature of the LCCS1 disease pathology (Nousiainen et al., 2008) . FRAP analysis of wild-type GFP-hGle1B R in hGLE1 siRNA-treated cells showed similar shuttling dynamics (t 1/2 10.3 min) as compared to the presence of endogenous hGle1 ( Figures 6B and 6D) . However, strikingly, the shuttling dynamics of GFP-Fin Major R were significantly slower (t 1/2 20.6 min) in hGLE1 siRNA-treated cells ( Figures 6B and 6D ). In sum, as in the LCCS1 disease state, when expressed as the only hGle1 in the siRNA-treated cells, Fin Major had inhibited nucleocytoplasmic shuttling. Thus, the defect in mRNA export was potentially due to the altered Fin Major oligomer structural state impacting nucleocytoplasmic shuttling.
hGle1 Requires the Coiled-Coil Domain for NPC Localization The hGle1 coiled-coil domain alone is not sufficient for nuclear rim localization (Kendirgi et al., 2005) . To further analyze for roles of the hGle1 coiled-coil domain in subcellular localization, a GFP-tagged h-gle1B lacking the coiled-coil domain (GFP-hgle1BDCC) was monitored. HeLa cells were cotransfected with plasmids expressing Pom121-mCherry and either GFP-hGle1B or a GFP-h-gle1BDCC. As reported, direct fluorescence microscopy in living cells revealed that GFP-hGle1B localized robustly to the nuclear rim overlapping with mCherry-Pom121 (Figure S5F ; Kendirgi et al., 2003) . In contrast, the nuclear rim signal intensity for GFP-h-gle1BDCC was markedly reduced (Figure S5F) . Immunoblotting showed similar expression levels for both GFP-tagged proteins ( Figure S5E ). FRAP analysis revealed that GFP-h-gle1BDCC shuttled faster than wild-type in both untreated (t 1/2 8. S5D and 6D) cells. Overall, the hGle1 oligomeric state modulated both NPC localization and nucleocytoplasmic dynamics.
DISCUSSION
In this report, we document a requirement for Gle1 self-association during mRNA export and uncover molecular defects underlying a lethal human disease LCCS1. Our results show that wild-type Gle1 protomers form discrete multimers and higher-order disk structures in vitro, with evidence for dimer formation happening in living cells. This self-association occurs through the essential Gle1 coiled-coil domain wherein the LCCS1 Fin Major disease alteration resides. Importantly, disk structures formed with the Fin Major coiled-coil domain are more disordered and malformed. Moreover, in HeLa cells, the Fin Major protein is defective in mRNA export and has slowed nucleocytoplasmic shuttling. We propose that LCCS1 disease pathology is due to perturbations in Gle1 oligomerization and shuttling that disrupt efficient nuclear export of mRNA at NPCs.
Coiled-coil domains are often utilized to mediate the formation of biological homo and hetero-oligomeric complexes and directly impact protein function (Burkhard et al., 2001) . We speculate that the Fin Major is a distinct perturbation of the hGle1 oligomeric structure compared to the h-gle1-DCC that does not oligomerize. This is based on the different effects on nucleocytoplasmic shuttling and steady-state NPC localization. Fin Major shuttles slower and is detected at the nuclear rim, contrasted with h-gle1-DCC which shuttles faster and is not rim localized. Thus, oligomerization might regulate Gle1 residence time at the NPC and hGle1 interactions with hNup155 and hCG1 could potentially facilitate Gle1 self-association. It is striking that the Fin Major analogous alleles in S. cerevisiae (y-gle1^P FQ ) specifically disrupt mRNA export function, but not yGle1 roles in translation initiation or termination, and that expressing y-gle1DCC rescues translation initiation. Thus, proper Gle1 self-association might only be strictly required at the NPC. Our in vitro studies reveal that Gle1 forms large oligomeric disk structures with an average diameter of 25.8 nm (Figure 2) . This was surprising, and such structures have not been previously reported with other isolated NPC-associated factors. It is tempting to speculate that these disk structures might be present in the NPC, which measures $105 nm in total diameter (Maimon et al., 2012) . However, there are no reports of such an NPCassociated disk-like particle in the published structural studies of NPCs in intact cells or of isolated NPCs or nuclear envelopes (Frenkiel-Krispin et al., 2010; Kiseleva et al., 2004; Maimon et al., 2012; Yang et al., 1998) . In intact cells, the electron density of such a disk might not be detected via tomography approaches. It is also possible that the Gle1 oligomer dissociates (partially or fully) during NPC or nuclear envelope isolation. Further studies are needed to investigate these possibilities and to determine the stoichiometry within the Gle1 oligomer in vitro and in vivo. Additionally, the presence of Gle1-binding partners in vivo will likely play important structural and/or regulatory roles affecting how Gle1 self-associates. Overall, using FRET microscopy, we observed hGle1 self-association in living cells (Figures 3A and 3B) and can conclude that, at a minimum, a dimer interaction exists at the NPC.
Gle1/IP 6 function at the NPC cytoplasmic face triggers Dbp5-mediated mRNP remodeling and facilitates directional mRNA export through the NPC (Alcá zar-Romá n et Tran et al., 2007; Weirich et al., 2006) . As part of the Dbp5 ATPase cycle, release of ADP from Dbp5 is mediated by Nup159 binding at the NPC cytoplasmic face (Noble et al., 2011) . Interestingly, Nup159 protomers dimerize by interaction with Dyn2 (Stelter et al., 2007) . Thus, both Dbp5 modulators at the NPC (Gle1 for ATP loading and ATPase activation and Nup159 for ADP release) are at least dimers at the NPC.
As the C-terminal yGle1 domain is sufficient in vitro for stimulating Dbp5 ATPase activity, there are at least two working models by which Gle1 self-association might function in mRNA export. First, oligomerization might promote Gle1 enrichment at the NPC and generate a self-organized platform of multiple C-terminal Gle1 domains. This, in turn, could allow stimulation of the same Dbp5 molecule multiple times, or multiple Dbp5 molecules simultaneously, to promote efficient mRNP remodeling and directional mRNA export. Preliminary support for this model can be drawn from the y-gle1DCC+GCN4 chimera complementation results, wherein the Gcn4 coiledcoil domain facilitates assembly of parallel aligned dimers (O'Shea et al., 1991) .
Alternatively, self-association might allow multiple distinct interactions with individual protomers in a Gle1 oligomer. Based on structural analysis of the yGle1 C-terminal domain (Montpetit et al., 2011) , it is possible that the binding interfaces for Dbp5 and Nup42 are mutually exclusive. Thus, Gle1 self-association would allow a dimer (or higher order oligomers) to coincidentally bind the NPC and activate Dbp5 for mRNA export. Our ongoing studies will be aimed at investigating the Nup-and Dbp5-binding interfaces on the oligomeric complex.
This work implicates Gle1 dysregulation of Dbp5's mRNP remodeling activity during mRNA export as the key molecular pathological event in LCCS1. As the RNA-binding protein composition of an mRNP dictates both its regulation and function during gene expression (Mü ller-McNicoll and Neugebauer, 2013) , altered mRNP remodeling during mRNA export likely has global cellular impacts. In addition to LCCS1, human genetic linkage analysis has identified additional GLE1 causal mutations that result in the lethal arthrogryposis with anterior horn cell disease (Nousiainen et al., 2008) . Further, recent deep sequencing studies report gle1 mutant alleles in other human diseases (AlQattan et al., 2012; Tzschach et al., 2012) . For these diseases, it is unclear whether or how hGle1 has cell-type-specific effects. Indeed, our studies of GLE1 depletion in zebrafish show potential impacts on multiple proliferative organ precursors (Jao et al., 2012) . With Gle1 uniquely positioned to modulate mRNP composition through regulation of multiple DBPs (Alcá zarRomá n et Bolger and Wente, 2011; Weirich et al., 2006) , we speculate that disruption of specific Gle1 mechanistic steps in export and/or translation results in different pathological outcomes.
Defective oligomerization of the SMN protein has been causally linked to some cases of spinal muscular atrophy (Lorson et al., 1998; Pellizzoni et al., 1999) . In this case, defects in SMN oligomerization cause ineffective assembly of the small nuclear RNPs and disruption of pre-mRNA splicing (Shpargel and Matera, 2005; Wan et al., 2005) . Our analysis of Gle1 self-association extends this paradigm for perturbations of RNP effector oligomerization and highlights altered mRNP remodeling as a molecular disease mechanism. Taken together, this work provides evidence for the cellular mechanism underlying the lethal human LCCS1 disease and impacts the broader understanding of the involvement of defective NPCs, altered mRNA transport, and misregulated gene expression in human disease.
EXPERIMENTAL PROCEDURES
Full details of the experimental procedures can be found in the Extended Experimental Procedures.
HeLa Cell Culture and Immunoblotting HeLa cells were cultured in complete medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals) at 37 C in 5% CO 2 . (Bolger et al., 2008) . Protein bands were visualized with a Li-COR Odyssey scanner.
Yeast Strains, Plasmids, and Two-Hybrid Analysis  Tables S3 and S4 list the plasmids and S. cerevisiae strains used in this study. Yeast strains were grown at indicated temperatures in either YPD (2% peptone, 2% dextrose, 1% yeast extract) or selective minimal media lacking appropriate amino acids and supplemented with 2% dextrose and 5-fluoroorotic acid (5-FOA; United States Biological) as needed at 1.0 mg/ml. Yeast twohybrid analysis was performed as described (Clontech Laboratories; Protocol No. PT3024-1), with activities reported normalized to G BD -hGle1B b-galactosidase levels.
In Situ Hybridization S. cerevisiae cells were processed as described (Wente and Blobel, 1993) . To localize poly(A) + RNA in HeLa cells, cells were fixed 72 hr post-siRNA treatment and processed as described (Watkins et al., 1998) . Both human and yeast cells were incubated with Cy3-conjugated oligo d(T) in hybridization buffer for 2 hr. Images were acquired using a microscope (BX50; Olympus), Olympus 1003/1.3 UPlanF1 objective (yeast samples) or Olympus 403/1.3 UPlanF1 objective (HeLa samples), and digital charge-coupled device camera (Orca-R2; Hamamatsu). Images were processed with ImageJ (National Institutes of Health [NIH]) or Adobe Photoshop CS6.
Translation Termination
Translation termination experiments using the tandem b-galactosidase-luciferase reporters were performed as described (Alcá zar-Romá n et al., 2010; Bolger et al., 2008) . , and GST-Dbp5 were purified as described (Tran et al., 2007) . The , , and MBP-h-gle1(1-365)-Fin Major were expressed in E. coli BL21-RIL (DE3) cells (Stratagene). Bacteria were lysed by sonication in buffer (200 mM NaCl, 20 mM Tris, pH 7.5), and the soluble fraction was used for affinity chromatography with either amylose resin (New England Biolabs) or glutathione-coupled Sepharose (GE Healthcare) according to manufacturer recommendations. Size exclusion chromatography with a S200 column (GE Healthcare) was used to further isolate complexes. Pyruvate kinase/lactate dehydrogenase-coupled ATPase assays (Noble et al., 2011) , soluble binding assays (Kendirgi et al., 2005) , and SVAU analysis (Roberts-Galbraith et al., 2010) were performed as described. Velocity scans were analyzed using Sedfit (version 14.0; Schuck and Rossmanith, 2000) . Size distributions were determined for a confidence level of p = 0.95, a resolution of n = 200, and sedimentation coefficients between 0 and 80 S.
Biochemical Analysis of Recombinant Proteins
Live-Cell Microscopy
All images were processed with ImageJ (NIH) or Adobe Photoshop CS6. Wild-type S. cerevisiae (W303) with plasmids harboring either y-GLE1-GFP (pBRR118b) or y-gle1-136^P FQ -GFP (pSW3779) were imaged as described (Noble et al., 2011 ) using a microscope (BX50; Olympus), Olympus 1003/1.3 UPlanF1 oil immersion objective, and digital charge-coupled device camera (Orca-R2; Hamamatsu). For HeLa cells, photoacceptor bleaching and sensitized emission FRET microscopy experiments were conducted on a confocal microscope (LSM710; Zeiss) using a Zeiss 403/1.1 C-Apochromat water objective. Photoacceptor bleaching was performed on HeLa cells cotransfected with (1) pSW3775 (Cer-hGLE1B) and pSW3774 (Venus-hGLE1B), (2) mCerulean3-C1 and pSW3774, or (3) pSW3977 (Venus-hGle1B(362À698)) and pSW3775. Cell volume was bleached by exciting at 514 nm throughout the targeted region, and FRET efficiency was calculated. For sensitized emission FRET measurements, HeLa cells were cotransfected with either pSW3775 and pSW3774 or mCerulean3 and pSW3774. A NFRET signal for indicated regions was determined using standard methods. FRAP was performed on untreated HeLa cells cotransfected with Pom121-mCherry and either GFP-hGLE1B (pSW1831), GFP-Fin Major (pSW3903), or GFP-hgle1BDCC (pSW3976) or on hGLE1 siRNA-treated HeLa cells cotransfected with Pom121-mCherry and either siRNA-resistant GFP-hGLE1B R (pSW3908),
GFP-Fin
Major R (pSW3945), or GFP-h-gle1BDCC (pSW3976). All FRAP microscopy experiments were conducted on a confocal microscope (LSM710; Zeiss) using a Zeiss 403/1.1 C-Apochromat water objective configured for timelapse acquisition. Bleaching was achieved by exciting at 488 nm throughout the targeted region.
Electron Microscopy
Uranyl-formate-stained samples were prepared as described (Ohi et al., 2004) . Samples were imaged on a FEI Morgagni electron microscope operated at an acceleration voltage of 100 kV. Images were recorded at a magnification of 22-36,0003 and collected using a 1K 3 1K charge-coupled device (CCD) camera (ATM). To prepare samples in vitrified ice, a holey carbon grid (Quantifoil Micro Tools) was glow-discharged and used to adsorb gel-filtration-purified human Gle1 particles. Grids were blotted and frozen in liquid ethane using a Vitrobot (FEI). Vitrified specimens were imaged under lowdose conditions at a nominal magnification of 100,0003 at defocus values ranging from À3 to À5 mm using a Gatan cryotransfer holder in a FEI Tecnai 200 kV electron microscope equipped with a field emission electron source (FEI) and 4K 3 4K Gatan Ultrascan CCD.
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